Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Tomoyuki HAYAMIZU"'
Autor:
Shigeki Nakamura, Masashi Mikami, Tomoyuki Hayamizu, Naohiro Yonemoto, Camille Moyon, Mark Gouldson, Catriona Crossan, Jeffrey Vietri, Kazumasa Kamei
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 546-560 (2024)
ABSTRACTBackground The 23-valent pneumococcal polysaccharide vaccine (PPSV23) is used in the Japanese National Immunization Program for older adults and adults with increased risk for pneumococcal disease, however, disease incidence and associated bu
Externí odkaz:
https://doaj.org/article/5239dd86e93040829e02bc8ac2bf6317
Autor:
Masayoshi Shinjoh, Kanae Togo, Tomoyuki Hayamizu, Naohiro Yonemoto, Junko Morii, Johnna Perdrizet, Kazumasa Kamei
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 485-497 (2024)
Background The Japanese National Immunization Program currently includes the pediatric 13 valent pneumococcal conjugate vaccine (PCV13) to prevent pneumococcal infections. We aimed to evaluate the cost-effectiveness of 20-valent PCV (PCV20) as a pedi
Externí odkaz:
https://doaj.org/article/71b05513c01b4d099126da3986cf1959
Publikováno v:
Kansenshogaku Zasshi. 96:15-24
Autor:
Kazuko Matsunaga, Tomoaki Hoshino, Tomoyuki Hayamizu, Tomotaka Kawayama, Takashi Kinoshita, Malcolm Johnson, Akihiro Kobayashi
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Tomotaka Kawayama,1 Takashi Kinoshita,1 Kazuko Matsunaga,2 Akihiro Kobayashi,3 Tomoyuki Hayamizu,4 Malcolm Johnson,5 Tomoaki Hoshino11Division of Respirology, Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine,
Autor:
Tomoko Betsuyaku, Mark James, Motokazu Kato, Hideki Hitosugi, Gerald Hagan, Akihiro Kobayashi, Keisaku Fujimoto, Paul Jones, Tomoyuki Hayamizu
Publikováno v:
1.1 Clinical Problems.
Background: The GOLD strategy proposes a COPD assessment framework based on symptoms and exacerbation risk;this study was conducted in Japanese patients with moderate-to-severe COPD using a protocol based upon monthly symptom assessment and occurrenc
Autor:
Katsuji Hashimoto, Tomoyuki Hayamizu, Gerald Hagan, Akihiro Kobayashi, Akinori Takeda, Takefumi Saito
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Saito T, Takeda A, Hashimoto K, et al. Int J Chron Obstruct Pulmon Dis. 2015;10:2393–2404.On page 2395, right column, line 3, “Philadelphia, PA, USA” should have read “Hoechberg, Germany”.On page 2396, Figure 2 was incorrect. The corrected
Autor:
Gerald Hagan, Takio Takaku, Tomoyuki Hayamizu, Takefumi Saito, Katsuji Hashimoto, Akinori Takeda, Akihiro Kobayashi
Publikováno v:
1.12 Clinical Problems - COPD.
Background: Triple therapy using salmeterol/fluticasone propionate (SFC) and tiotropium bromide (TIO) is used to treat chronic obstructive pulmonary disease (COPD), but fewevidence have been published in Japanese COPD patients with a lower dose of in
Autor:
Nobuhisa Ishikawa, Akihiro Kobayashi, Nobuoki Kohno, Noboru Hattori, Malcolm Johnson, Tomoyuki Hayamizu
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Nobuhisa Ishikawa,1 Noboru Hattori,2 Nobuoki Kohno,2 Akihiro Kobayashi,3 Tomoyuki Hayamizu,4 Malcolm Johnson5 1Department of Respiratory Medicine, Hiroshima Prefectural Hospital, Hiroshima, Japan; 2Department of Molecular and Internal Medicine, Hiros
Methylated Nε-dansyl-l-lysine as a fluorogenic reagent for the chiral separation of carboxylic acids
Publikováno v:
Journal of Chromatography B: Biomedical Sciences and Applications. 710:211-218
Dansyl amino acids having a free amino group and an asymmetric carbon atom were examined as a labeling reagent for chiral compounds containing carboxylic moieties to realize enantiomeric separation as well as fluorimetric determination. We tested dan
Autor:
Tomotaka Kawayama, Takashi Kinoshita, Kazuko Matsunaga, Akihiro Kobayashi, Tomoyuki Hayamizu, Johnson, Malcolm, Tomoaki Hoshino
Publikováno v:
International Journal of COPD; Feb2016, Vol. 11, p295-303, 9p